Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib

Jae-Yong Kwak

Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib

Jae-Yong Kwak

Department of Medicine

Research output: Contribution to journal › Journal article › peer-review

Original language	Korean
Journal	Annals of Hematology
State	Published - 2010.07.1

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{8331199901d3432781e74fa98cd9247a,

title = "Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib",

author = "Jae-Yong Kwak",

year = "2010",

month = jul,

day = "1",

language = "Korean",

journal = "Annals of Hematology",

issn = "0939-5555",

}